Bleeding during veno-venous ECMO cannot reliably be predicted by rotational thrombelastometry (ROTEM™)

Abstract

Introduction:

Veno-venous extracorporeal membrane oxygenation (vvECMO) used for respiratory support is associated with clinical bleeding in at least one third of patients. Mechanisms promoting bleeding, like acquired von Willebrand syndrome, cannot be identified by routine coagulation tests. This study was performed to evaluate rotational Thrombelastography (ROTEM™) for specific results predicting bleeding events during vvECMO.

Methods:

Five hundred and thirty-four ROTEM™ analyses of 57 patients over 574 days have been evaluated. Patients were graded into three groups according to the severity of bleeding, following the Freiburg ECMO bleeding assessment. ROTEM™ results and basic as well as comprehensive laboratory coagulation tests have been compared among the three groups and overall between defined time points.

Results:

Fourteen patients (25 %) presented without bleeding, 22 patients (39 %) showed mild bleeding and 21 patients (36 %) became evident with relevant clinical bleeding. No bleeding shock and no fatal bleeding event occurred. No case of hyperfibrinolysis was observed. Neither a statistical difference for ECMO blood flow nor duration of therapy among the groups could be shown.

The only significant difference was clotting time (CT) in the InTEM analysis, with a median (IQR) of 175 (37.5) seconds in Group 1, 190 (54.5) seconds in Group 2 and 204 (90) seconds in Group 3.

When comparing overall ROTEM™ analyses between defined time points, continuous worsening of CT can be found in ExTEM, FibTEM and ApTEM. Reduced A10, A20 and congruently maximum clot firmness, especially, developed in ExTEM and ApTEM and with a minor characteristic in InTEM, but not in FibTEM. ROTEM™ and coagulation-parameter results before 19 clinical relevant bleeding episodes compared to all other results only showed differences in FibTEM.

Conclusion:

ROTEM™ as a functional viscoelastic analysis does not provide additional information to basic and comprehensive laboratory tests during vvECMO. Bleeding events cannot be predicted by the means of specific ROTEM™ results.

Keywords

ECMO ROTEM™bleeding point of care thrombosis hyperfibrinolysis acquired von Willebrand syndrome fibrinogen deficiency factor XIII deficiency

Get full access to this article

View all access options for this article.

References

Karagiannidis

Brodie

Strassmann

et al . Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Inten Care Med 2016; 42: 889-896.

Thiagarajan

Barbaro

Rycus

et al . Extracorporeal Life Support Organization Registry International Report 2016. ASAIO J 2017; 63: 60–67.

Zangrillo

Landoni

Biondi-Zoccai

et al . A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Res 2013;15: 172–178.

Gattinoni

Carlesso

Langer

Clinical review: extracorporeal membrane oxygenation. Crit Care 2011; 15: 243.

Combes

Bacchetta

Brodie

Muller

Pellegrino

Extracorporeal membrane oxygenation for respiratory failure in adults. Curr Opin Crit Care 2012; 18: 99–104.

Luyt

Brechot

Demondion

et al . Brain injury during venovenous extracorporeal membrane oxygenation. Int Care Med 2016; 42: 897-907.

Kalbhenn

Schmidt

Nakamura

Schelling

Rosenfelder

Zieger

Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy. J Athero Thromb 2015; 22: 265–271.

Kalbhenn

Wittau

Schmutz

Zieger

Schmidt

Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion 2015; 30: 675–682.

Panigada

Artoni

Passamonti

et al . Hemostasis changes during veno-venous extracorporeal membrane oxygenation for respiratory support in adults. Minerva Anestesiol 2016; 82: 170–179.

10.

Kalbhenn

Hemostasis and extracorporeal membrane oxygenation: bleeding cannot be seen in aliquots. Crit Care Med 2016; 44: e591–592.

11.

Hartert. Blutgerinnungsstudien mit der Thrombelas-tographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948(26 ):577–83.

12.

Calatzis

AN.

A new technique for fast and specific intraoperative coagulation monitoring. Eur Surg Res 1996; 28: 47–48.

13.

Schochl

Cotton

Inaba

et al . FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15: R265.

14.

Gorlinger

Dirkmann

Hanke

et al . First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiol 2011; 115: 1179–1191.

15.

Laine

Niemi

Suojaranta-Ylinen

et al . Decreased maximum clot firmness in rotational thromboelastometry (ROTEM(R)) is associated with bleeding during extracorporeal mechanical circulatory support. Perfusion 2016; 31: 625-633.

16.

Prakash

Wiersema

Bihari

Roxby

Discordance between ROTEM(R) clotting time and conventional tests during unfractionated heparin-based anticoagulation in intensive care patients on extracorporeal membrane oxygenation. Anaesth Int Care 2016; 44: 85–92.

17.

Nair

Hoechter

Buscher

et al . Prospective observational study of hemostatic alterations during adult extracorporeal membrane oxygenation (ECMO) using point-of-care thromboelastometry and platelet aggregometry. J Cardiothorac Vasc Anesth 2015; 29: 288–296.

18.

Bolliger

Zenklusen

Tanaka

KA.

Point-of-care coagulation management algorithms during ECMO support: are we there yet?

Minerva Anestesiol 2016; 82: 1000-1009.

19.

Organization ELS. ELSO Anticoagulation Guideline.

20.

(ELSO) ELSO. Supplement to the ELSO General Guidelines. Guidelines for Adult Respiratory Failure Version 13.

21.

Krueger

Schmutz

Zieger

Kalbhenn

Venovenous extracorporeal membrane oxygenation with prophylactic subcutaneous anticoagulation only: an observational study in more than 60 patients. Artif Organs 2017; 41: 186–192.

22.

Aubron

DePuydt

Belon

et al . Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation. Ann Int Care 2016; 6: 97.

23.

Ranucci

The conundrum of anticoagulation and hemostatic management in ECMO patients. Minerva Anestesiol 2016; 82: 147–148.

24.

Esper

Levy

Waters

Welsby

IJ.

Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion. Anesth Analg 2014; 118: 731–743.

25.

Ang

Teo

Lim

Leou

Tien

Koh

MB.

Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation – a single centre experience. Vox Sang 2009; 96: 34–43.

26.

Lonergan

Herr

Kon

et al . The HAT Score - a simple risk stratification score for coagulopathic bleeding during adult extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth 2016; 31:863-868.